Every SEC Form 3/4/5 on record for this filer (CIK 1661254) — 2 issuers, 193 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| LLY | ELI LILLY & Co | EVP,Pres LLY Oncology&HdCorpBD | 2021-09-07 → 2026-02-11 | 13 | $647,360 |
| LOXO | Loxo Oncology, Inc. | Chief Operating Officer · lapsed | 2016-03-08 → 2019-02-15 | 24 | −$12M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| LLY | 2025-08-13 | Buy | 1,000 | $647.36 | $647,360 | 20,562 |
1 of 2 issuers are covered and open a security page; the rest are on file here only.